Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration

NCT04263181 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04263181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04263181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Active, not recruiting
Start date
January 29, 2020
Completion date
January 31, 2027
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, myelodysplastic syndromes